Hm Payson & CO Idexx Laboratories Inc Transaction History

Hm Payson & CO

$5.37 Billion
Q1 2024

A detailed history of Hm Payson & CO transactions in Idexx Laboratories Inc stock. As of the latest transaction made, Hm Payson & CO holds 25,205 shares of IDXX stock, worth $12.3 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

25,205

Previous 26,514 4.94%

Holding current value

$12.3 Million

Previous $14.7 Million 7.53%

% of portfolio

0.25%

Previous 0.31%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Jun 20, 2024	SELL	$515.08 - $576.87 $674,239 - $755,122	-1,309 Reduced 4.94%	25,205 $13.6 Million
Q4 2023 Feb 13, 2024	BUY	$391.37 - $557.56 $3,913 - $5,575	10 Added 0.04%	26,514 $14.7 Million
Q3 2023 Nov 06, 2023	BUY	$432.42 - $556.67 $283,235 - $364,618	655 Added 2.53%	26,504 $11.6 Million
Q2 2023 Jul 17, 2023	SELL	$450.7 - $503.61 $59,041 - $65,972	-131 Reduced 0.5%	25,849 $13 Million
Q1 2023 Apr 18, 2023	SELL	$406.01 - $514.59 $602,518 - $763,651	-1,484 Reduced 5.4%	25,980 $13 Million

Q4 2022 Feb 06, 2023	SELL	$324.64 - $441.27 $52,267 - $71,044	-161 Reduced 0.58%	27,464 $11.2 Million
Q3 2022 Oct 25, 2022	SELL	$325.8 - $407.78 $22,806 - $28,544	-70 Reduced 0.25%	27,625 $9 Million
Q2 2022 Aug 15, 2022	SELL	$327.37 - $553.44 $707,446 - $1.2 Million	-2,161 Reduced 7.24%	27,695 $9.71 Million
Q1 2022 May 12, 2022	BUY	$466.52 - $631.01 $25,192 - $34,074	54 Added 0.18%	29,856 $16.3 Million
Q4 2021 Feb 15, 2022	BUY	$586.54 - $666.48 $205,289 - $233,268	350 Added 1.19%	29,802 $19.6 Million
Q3 2021 Nov 30, 2021	SELL	$621.9 - $705.76 $4,975 - $5,646	-8 Reduced 0.03%	29,452 $18.3 Million
Q2 2021 Aug 17, 2021	SELL	$486.36 - $637.08 $3,890 - $5,096	-8 Reduced 0.03%	29,460 $18.6 Million
Q1 2021 Jun 15, 2021	BUY	$465.18 - $551.79 $55,821 - $66,214	120 Added 0.41%	29,468 $14.4 Million
Q4 2020 Mar 10, 2021	SELL	$383.85 - $499.87 $345,081 - $449,383	-899 Reduced 2.97%	29,348 $14.7 Million
Q3 2020 Dec 21, 2020	SELL	$334.54 - $406.31 $50,515 - $61,352	-151 Reduced 0.5%	30,247 $11.9 Million
Q2 2020 Aug 13, 2020	SELL	$230.66 - $330.16 $46,132 - $66,032	-200 Reduced 0.65%	30,398 $10 Million
Q1 2020 Jul 01, 2020	SELL	$182.94 - $290.97 $662,974 - $1.05 Million	-3,624 Reduced 10.59%	30,598 $7.41 Million
Q4 2019 Feb 18, 2020	BUY	$248.66 - $285.01 $13,427 - $15,390	54 Added 0.16%	34,222 $8.94 Million
Q3 2019 Nov 12, 2019	BUY	$260.07 - $289.93 $829,623 - $924,876	3,190 Added 10.3%	34,168 $9.29 Million
Q2 2019 Aug 15, 2019	SELL	$215.53 - $275.33 $100,652 - $128,579	-467 Reduced 1.49%	30,978 $8.53 Million
Q1 2019 Jul 31, 2019	BUY	$178.02 - $225.69 $5.6 Million - $7.1 Million	31,445 New	31,445 $7.03 Million
Q4 2018 Feb 15, 2019	SELL	$176.18 - $248.92 $3.79 Million - $5.36 Million	-21,519 Closed	0 $0
Q3 2018 Nov 30, 2018	SELL	$218.82 - $254.46 $422,322 - $491,107	-1,930 Reduced 8.23%	21,519 $5.37 Million
Q2 2018 Aug 27, 2018	SELL	$185.56 - $227.9 $18,556 - $22,790	-100 Reduced 0.42%	23,449 $5.11 Million
Q1 2018 May 14, 2018	SELL	$157.81 - $204.73 $3,156 - $4,094	-20 Reduced 0.08%	23,549 $4.51 Million
Q4 2017 Feb 16, 2018	BUY	$147.68 - $168.37 $230,823 - $263,162	1,563 Added 7.1%	23,569 $3.69 Million
Q3 2017 Nov 06, 2017	BUY	$150.32 - $166.46 $3.31 Million - $3.66 Million	22,006	22,006 $3.42 Million

Others Institutions Holding IDXX

# of Institutions

1,212

Shares Held

71.7M

Call Options Held

168K

Put Options Held

394K

View Full List

About IDEXX LABORATORIES INC

Ticker IDXX
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 83,253,696
Market Cap $40.6B
Description
IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...

More about IDXX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hm Payson & CO, based on Form 13F filings with the SEC.

News

Stay updated on Hm Payson & CO with notifications on news.

Account